Delivery Order SPE2DB22D3301-SPE2DB23FZ1LA
Award Date 7/18/23
Potential Completion Date 7/19/23
Potential Value $1.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The $3,455.25 firm fixed-price contract is for the supply of MITIGO 500 MG/20 ML VIAL 20ML, a pharmaceutical product. The delivery order has an ultimate completion date of October 7, 2024. Amerisourcebergen is a key vendor for DLA Troop Support Medical, holding an Indefinite Delivery Contract valued up to $999,999,999 through...
- The Defense Logistics Agency awarded a $2,448 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Mitomycin 40 mg vials, with completion targeted for September 16, 2025. This firm fixed-price contract is a non-set-aside award executed as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999 through December 2026. The pharmaceutical will be...
- The Defense Logistics Agency awarded a $5,326 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562312732 units of 5 mg Mitomycin vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to its Conshohocken, Pennsylvania facility by September 27, 2023 to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were identified. The delivery order was issued against an existing DLA contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,146.40 to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Mitomycin 5 mg vials. This is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and represents a non-set-aside competitive award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $565 to Amerisourcebergen Drug Corporation to supply 4561985811 Mitomycin 5 mg vials. As the prime contractor, Amerisourcebergen will deliver the requested pharmaceutical products to a location in Conshohocken, Pennsylvania by August 30, 2023 under the terms of the order. The Defense Logistics Agency utilizes contracts such as this to efficiently procure necessary medical supplies for the U.S....
- The Defense Logistics Agency awarded a $2,754.00 delivery order to AmerisourceBergen Drug Corp for the supply of Mitomycin 20 mg vials under a firm fixed-price contract with an ultimate completion date of October 27, 2025. This competitively awarded, non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The...
- Defense Logistics Agency, an agency of the Department of Defense, awarded a $10,800 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561406930 units of the chemotherapy drug mitomycin at 40 mg per vial. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in July 2023. The delivery order was issued under an existing Prime Vendor contract vehicle to supply pharmaceuticals and other medical commodities in...
- The Defense Logistics Agency awarded a $6,758 delivery order to Amerisourcebergen Drug Corporation for 4562195244 mitomycin 20 mg vials. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a facility in Conshohocken, Pennsylvania by September 18, 2023 under the firm fixed price contract awarded on September 15, 2023. The Defense Logistics Agency utilizes indefinite delivery/indefinite quantity contracts to support medical readiness for the Department of...
- The Defense Logistics Agency (DLA) awarded a $1,492.08 delivery order to AmerisourceBergen Drug Corp for Mresvia 50 micrograms/0.5 milliliter syringes on September 26, 2025, with an ultimate completion date of October 20, 2025. This competitive, non-set-aside contract utilizes firm fixed pricing and is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The...
- The Defense Logistics Agency awarded a $290,420 delivery order to Amerisourcebergen Drug Corporation for 4561807750 MIMVEY 1-0.5 MG TABLET 28S. The firm fixed price order is being performed in Conshohocken, Pennsylvania under the prime contractor's corporate office division from August 14-15, 2023. The Defense Logistics Agency facilitates the delivery of medical supplies and pharmaceuticals to support the United States Department of Defense. No subcontractors or set aside designations were...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB23FZ1LADelivery Order
The Defense Logistics Agency awarded a $1,847 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 500 mg/20 ml vials of Mitigo. As the prime contractor, Amerisourcebergen will deliver 20 ml vials of the specified pharmaceutical to the location in Conshohocken, Pennsylvania within the period of performance between July 18-19, 2023. The delivery order was placed against an existing DLA contract vehicle in support of the Agency's medical supply procurement programs. No set aside provisions or subcontractors were identified in the award information provided.
Generated 12/24/23, 9:02 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 7/18/23 |